Univest
Univest
  • Markets
  • 3 Specialty Export Formulations, Cardiac and CNS Leader and Contract Injectables Stocks With a Strong Future Roadmap: Rubicon Research, Torrent Pharmaceuticals and Gland Pharma

    • October 22, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Specialty Export Formulations, Cardiac and CNS Leader and Contract Injectables Stocks With a Strong Future Roadmap: Rubicon Research, Torrent Pharmaceuticals and Gland Pharma

    Pharma Exports and Chronic Care Stocks with a strong future roadmap: Rubicon Research, Torrent Pharmaceuticals and Gland Pharma. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Global Pharma Franchise, Sterile Injectables and Anti-Retroviral Ingredients Stocks With a Strong Future Roadmap: Lupin, Gland Pharma and Laurus Labs

    • October 22, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Global Pharma Franchise, Sterile Injectables and Anti-Retroviral Ingredients Stocks With a Strong Future Roadmap: Lupin, Gland Pharma and Laurus Labs

    Export-focused Pharma Stocks with a strong future roadmap: Lupin, Gland Pharma and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Sterile Injectables, Finished Dosages and Integrated Generics Stocks With a Strong Future Roadmap: Gland Pharma, Granules India and Aurobindo Pharma

    • October 22, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Sterile Injectables, Finished Dosages and Integrated Generics Stocks With a Strong Future Roadmap: Gland Pharma, Granules India and Aurobindo Pharma

    Generic Drug Manufacturing Stocks with a strong future roadmap: Gland Pharma, Granules India and Aurobindo Pharma. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Sterile Injectables, Chronic Care Brands and Biologics Maker Stocks With a Strong Future Roadmap: Gland Pharma, Eris Lifesciences and Shilpa Medicare

    • October 21, 2026
    • Posted by: Lakshit Sharma
    • Category: Best Stocks
    No Comments
    3 Sterile Injectables, Chronic Care Brands and Biologics Maker Stocks With a Strong Future Roadmap: Gland Pharma, Eris Lifesciences and Shilpa Medicare

    Injectable and Specialty Pharma Stocks with a strong future roadmap: Gland Pharma, Eris Lifesciences and Shilpa Medicare. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.

    read more
  • Raja Venkatraman Stock Picks for 8 October: Gland Pharma Above Rs 3,010, Sagility Above Rs 44 and Petronet LNG Above Rs 298, With Targets, Fundamentals, Risks and How to Use Breakout Calls Safely

    • October 8, 2026
    • Posted by: Harsh Piplani
    • Category: News
    No Comments
    Raja Venkatraman Stock Picks for 8 October: Gland Pharma Above Rs 3,010, Sagility Above Rs 44 and Petronet LNG Above Rs 298, With Targets, Fundamentals, Risks and How to Use Breakout Calls Safely

    Raja Venkatraman stock picks: Gland Pharma, Sagility and Petronet LNG with breakout levels, targets, fundamentals and risks.

    read more
  • Gland Pharma Share Price Jumps 16.22% to Rs 2,170, Hits 52-Week High on Q4 FY26 Results: PAT Nearly Doubles, CDMO Grows 65%

    • May 18, 2026
    • Posted by: Kunal Singla
    • Category: Market
    No Comments
    Gland Pharma Share Price Jumps 16.22% to Rs 2,170, Hits 52-Week High on Q4 FY26 Results
    read more